Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05698043

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

Hypertension and Dyslipidemia Clinical Trial

Official title:
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and the Tolerability of CKD-386(5) With Co-administration of D013, D326, and D337 in Healthy Adult Volunteers

Clinical Trial Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-386(5)

Clinical Trial Description

An open label, randomized, single dose, 2-sequence, 4-period, cross-over clinical trial to evaluate the pharmacokinetics and the tolerability of CKD-386(5) with co-administration of D013, D326, and D337 in healthy adult volunteers ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05698043
Study type Interventional
Source Chong Kun Dang Pharmaceutical
Contact
Status Completed
Phase Phase 1
Start date July 17, 2023
Completion date September 26, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT05549401 - Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 Phase 1
Completed NCT05552495 - Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions Phase 1
Completed NCT04987970 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg Phase 1
Completed NCT04587206 - A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 Phase 1
Completed NCT02933658 - Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers Phase 1
Completed NCT05335044 - Study to Evaluate the Safety and Pharmacokinetics of CKD-331 Phase 1
Completed NCT05245084 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg Phase 1
Completed NCT04883658 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) Phase 1
Completed NCT04660370 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 Phase 1
Completed NCT04673864 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 Phase 1
Completed NCT05192356 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) Phase 1
Completed NCT04694989 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) Phase 1
Completed NCT05749861 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5) Phase 1
Completed NCT04554953 - A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia